Penumbra, Inc Lease, Cost
Penumbra, Inc (PEN) reported Lease, Cost of $40.34 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-02-25
- Penumbra, Inc lease, cost for the quarter ending 2022-12-31 was $8.97M, a 17.67% increase year-over-year.
- Penumbra, Inc lease, cost for the quarter ending 2022-09-30 was $8.85M, a 39.58% increase year-over-year.
- Penumbra, Inc lease, cost for the quarter ending 2022-06-30 was $8.77M, a 97.19% increase year-over-year.
- Penumbra, Inc lease, cost for the quarter ending 2022-03-31 was $8.41M, a 86.73% increase year-over-year.
- Penumbra, Inc lease, cost for fiscal 2025 was $40.34M, a 1.76% increase from fiscal 2024.
- Penumbra, Inc lease, cost for fiscal 2024 was $39.64M, a 2.93% increase from fiscal 2023.
- Penumbra, Inc lease, cost for fiscal 2023 was $38.52M, a 10.01% increase from fiscal 2022.
- Penumbra, Inc lease, cost for fiscal 2022 was $35.01M, a 52.73% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $40.34M 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $39.64M 10-K · filed 2026-02-25 | |||
| 2023-12-31 | $38.52M 10-K · filed 2026-02-25 | |||
| 2022-12-31 | $8.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $17.82M derived: sum of 2 quarters · filed 2025-02-18 | $26.60M derived: sum of 3 quarters · filed 2025-02-18 | $35.01M 10-K · filed 2025-02-18 |
| 2022-09-30 | $8.85M 10-Q · filed 2022-11-03 | $17.62M derived: sum of 2 quarters · filed 2022-11-03 | $26.03M 10-Q · filed 2022-11-03 | $33.66M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $8.77M 10-Q · filed 2022-08-05 | $17.19M 10-Q · filed 2022-08-05 | $24.81M derived: sum of 3 quarters · filed 2024-02-22 | $31.15M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $8.41M 10-Q · filed 2022-05-03 | $16.04M derived: sum of 2 quarters · filed 2024-02-22 | $22.38M derived: sum of 3 quarters · filed 2024-02-22 | $26.83M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $7.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $13.97M derived: sum of 2 quarters · filed 2024-02-22 | $18.41M derived: sum of 3 quarters · filed 2024-02-22 | $22.92M 10-K · filed 2024-02-22 |
| 2021-09-30 | $6.34M 10-Q · filed 2022-11-03 | $10.79M derived: sum of 2 quarters · filed 2022-11-03 | $15.29M 10-Q · filed 2022-11-03 | $19.38M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $4.45M 10-Q · filed 2022-08-05 | $8.96M 10-Q · filed 2022-08-05 | $13.04M derived: sum of 3 quarters · filed 2023-02-23 | $17.41M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $4.50M 10-Q · filed 2022-05-03 | $8.59M derived: sum of 2 quarters · filed 2023-02-23 | $12.96M derived: sum of 3 quarters · filed 2023-02-23 | $17.31M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $4.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $8.46M derived: sum of 2 quarters · filed 2023-02-23 | $12.81M derived: sum of 3 quarters · filed 2023-02-23 | $17.05M 10-K · filed 2023-02-23 |
| 2020-09-30 | $4.37M 10-Q · filed 2021-11-03 | $8.72M derived: sum of 2 quarters · filed 2021-11-03 | $12.96M 10-Q · filed 2021-11-03 | $16.69M derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | $4.35M 10-Q · filed 2020-08-03 | $8.76M 10-Q · filed 2020-08-03 | $12.32M derived: sum of 3 quarters · filed 2021-02-23 | $15.03M derived: sum of 4 quarters · filed 2021-02-23 |
| 2020-03-31 | $4.41M 10-Q · filed 2020-05-07 | $7.97M derived: sum of 2 quarters · filed 2021-02-23 | $10.68M derived: sum of 3 quarters · filed 2021-02-23 | $13.21M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $6.28M derived: sum of 2 quarters · filed 2021-02-23 | $8.81M derived: sum of 3 quarters · filed 2021-02-23 | $11.33M 10-K · filed 2021-02-23 |
| 2019-09-30 | $2.71M 10-Q · filed 2019-11-07 | $5.25M derived: sum of 2 quarters · filed 2020-08-03 | $7.77M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.53M 10-Q · filed 2020-08-03 | $5.06M 10-Q · filed 2020-08-03 | ||
| 2019-03-31 | $2.53M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |